Comparison between vitamin D3, triamcinolone, and fractional CO2 laser for treatment of keloids and hypertrophic scars

Clinical and histopathologic evaluation of intralesional injection of vitamin D3, triamcinolone, and fractional carbon dioxide in treatment of keloids; a prospective randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201806003302197

Enrollment

Registered

2018-04-06

Start date

2018-04-09

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases Keloids and hyoertrophic scars

Interventions

Vitamin D3

Triamcinolone acetonide injection

fractional CO2 laser

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age: >18 years both sexes all skin phototypes

Exclusion criteria

Exclusion criteria: pregnancy and lactation age < 18 years history of current treatment for keloids history of treatment for keloids within 6 months prior to the study history of hypersensitivity to triamcinolone or vitamin D3 history of systemic retenoids within 6 months prior to study any dermatologic diseases other than keloid hypertrophic and atrophic scars

Design outcomes

Primary

Measure	Time frame
degree of improvement;patient`s satisfaction	—

Secondary

Measure	Time frame
Persistence of the response, improvement, or worsening	—

Countries

Egypt

Contacts

Public ContactRania Abdelghani

Faculty of Medicine for Girls, Al-Azhar University

rania_abdulghani@hotmail.com+2-01283433887

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026